Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tempest Therapeutics Inc
(NQ:
TPST
)
1.420
+0.060 (+4.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempest Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
April 09, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 05, 2024
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.
Via
Benzinga
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
April 04, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023
March 19, 2024
TPST stock results show that Tempest Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Tempest Reports Year End 2023 Financial Results and Provides Business Update
March 19, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
March 14, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
March 12, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
“Market Mavericks: Stocks Creating Ripples of Success” CLNV, TPST, HNRC, INPX
November 15, 2023
Via
AB Newswire
Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
March 05, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
February 26, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Therapeutics Announces Groundbreaking Advances in Liver Cancer Treatment, Showcasing Exceptional Efficacy and Safety Data at ASCO Annual Meeting 2024
January 30, 2024
Via
AB Newswire
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
Via
Benzinga
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2024
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Intelligent Bio (NASDAQ: INBS) Surges Massively Among Stocks Making BUZZ:TPST, HNST, LTRN, VTAK
November 14, 2023
Via
AB Newswire
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
November 09, 2023
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Biggest Short Squeeze Stocks Of The Week: Two Biotech Stocks Move Up To Top The List
October 31, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 24, 2023
Via
Benzinga
MarketBeat Week in Review – 10/16 - 10/20
October 21, 2023
All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Interest Rates
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 18, 2023
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 18, 2023
Via
Benzinga
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 18, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
What's Going On With Tempest Therapeutics Stock Today?
October 17, 2023
Tempest Therapeutics, Inc. (NASDAQ: TPST) shares are continuing a recent streak of volatility Tuesday. TPST shares are up nearly 3500% over the last five days.
Via
Benzinga
The Secrets Behind a 4000% Biotech Stock Surge
October 17, 2023
Last Wednesday, shares of Tempest Therapeutics (NASDAQ: TPST), a small-cap stock you have probably never heard of, surged over 4000%.
Via
MarketBeat
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.